Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Foresight VCTs invests in HomeLink Healthcare Limited, a provider of Hospital-at-Home and Virtual Ward services supporting the NHS

by Staff GBAF Publications Ltd
0 comment

 

  •     A specialist provider of clinical services to patients in their own homes, alleviating pressure on the NHS, freeing up vital bed space, saving time and reducing costs
  •     Funds will be used to expand this successful innovative solution across the UK and allow investment in Virtual Ward and telematic technologies
  •     HomeLink Healthcare can now scale their service to meet the needs of a rapidly growing market benefitting from significant industry tailwinds

 

London, 20 April 2022: Foresight Group LLP (“Foresight”), a leading listed infrastructure and SME investment manager, has made a £2.15m investment into HomeLink Healthcare Limited (“HomeLink” or “the Company”) from Foresight VCT and Foresight Enterprise VCT. Existing shareholders also invested £500,000 to further support HomeLink’s growth.

Formed in 2015, HomeLink has provided “hospital-at-home” services since 2018. The Company employs highly qualified and experienced nurses and rehabilitation teams to support the NHS – by providing services to patients in their own homes. These services deliver a range of clinical interventions, including wound care, intravenous therapies, physiotherapy, and rehabilitation. HomeLink has also expanded into the rapidly growing remote monitoring practice and offers a “virtual ward” solution.

Bed-blocking is an endemic issue across the NHS with significant delays in the discharge of patients and increasing hospital admissions due to a lack of viable alternatives. This is exacerbated by demographic shifts and the pandemic. HomeLink relieves these pressures by freeing up vital hospital bed space, providing a better experience for patients at home, reducing hospital admissions, and facilitating the efficient discharge of patients.

 

Demand for HomeLink’s services is forecast to grow significantly because of recent government initiatives around efficiency, the elective surgery backlog and NHS England, which has put in place a number of supportive measures. This includes increased funding for community care and virtual wards.

This funding will support the scaling of the business by expanding the clinical team, allowing HomeLink to meet the demands of clients and prospects. HomeLink will invest in supportive technologies and plans to expand outside its current geography into new hospitals and regions. The Company also aims to explore additional treatment pathways and grow its “virtual ward” offering.

 

Foresight is one of the UK’s most active investors in smaller companies. For close to four decades, Foresight has supported nearly 300 smaller companies through various economic cycles. Foresight partners with promising smaller companies across all sectors and deal stages to deliver long term sustainable growth and high-quality, local jobs.

Commenting on the investment, Jill Ireland, CEO and Clinical Director of HomeLink Healthcare, said: We are delighted to be working with Foresight; their investment will create opportunities and allow development into new services and territories. It will also enable HomeLink to extend innovative clinical home care services. By working in partnership with the NHS, HomeLink will be able to care for more patients at home, freeing up hospital beds and provide the much-needed additional Hospital-at-Home services care, which will help to address inequalities in access to community-based care.”

Nick Mettyear, Senior Investment Manager at Foresight, added: “We are excited to be supporting HomeLink on the next phase of its growth journey. HomeLink’s quality of care is of the highest standard and provides patients with an improved service in the familiar surroundings of their own home. The team is well placed to provide mission-critical services to the NHS and help ease existing pressures in the NHS that have been exacerbated by the pandemic.”

 

Advisers to Foresight:

Financial DD:                                 PKF Francis Clarke

Legal DD:                                        RW Blears          

Commercial DD:                        WhiteCap Consulting 

Management DD:                     Catalysis

Cyber DD:                                   KryptoKloud

Insurance DD:                           Lockton